Flow cytometric analyses of TILs revealed that L-NAME combined with an anti-PD-1 blockade tended to decrease tumor-infiltrating CD4+FOXP3+ regulatory T cells, and significantly increased the CD8+/CD4+FOXP3+ ratio in MCA205WT tumors (Fig. 6c). This evidence concerns the gene PDCD1 and neoplasm.